TRexBio IPO: Date, Status and What We Know
FiledUnited States · Nasdaq Global Select MarketTRXB
IPO facts
- Status
- Filed
- Market
- United States
- Country
- United States
- Exchange
- Nasdaq Global Select Market
- Ticker
- TRXB
- Sector
- Biopharmaceuticals (immune medicines)
- Filing date
- First trading day
- Not announced
- Price range
- Not announced
- Offering size
- Not announced
- Last valuation
- Not announced
About TRexBio
TRexBio is a clinical-stage biopharmaceutical company that develops medicines based on regulatory T cells in tissue, aimed at autoimmune and inflammatory diseases.
IPO notes
TRexBio publicly filed its Form S-1 on 18 September 2026. It has applied to list its common stock on the Nasdaq Global Select Market under TRXB; the filing leaves the number of shares and the price range blank (sec.gov). No pricing date had been announced as of 5 October 2026.
Other IPOs in this market
Sources
- sec.gov · Form S-1 registration statement ·
Named as plain text with what each source states and the date it was checked.